Nektar Therapeutics (NASDAQ:NKTR)

3.20
Delayed Data
As of Sep 30
 +0.16 / +5.26%
Today’s Change
2.96
Today|||52-Week Range
18.69
-76.31%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Robin Howard W
President & Chief Executive Officer
Sale11/16/202142,773$13.16$562.9K-75.92%
Zalevsky Jonathan
Chief Research & Development Officer
Sale8/18/202273,716$4.65$342.8K-31.62%
Labrucherie Gilbert M
Chief Operating & Financial Officer & Senior VP
Sale11/16/202121,149$13.16$278.3K-75.92%
Zalevsky Jonathan
Chief Research & Development Officer
Sale11/16/202120,869$13.16$274.6K-75.92%
Greer R Scott
Director
Buy11/09/202112,500$12.80$160.0K-76.85%
Robin Howard W
President & Chief Executive Officer
Sale5/16/202236,529$3.95$144.3K-17.53%
Robin Howard W
President & Chief Executive Officer
Sale2/16/202212,480$10.95$136.7K-71.40%
Zalevsky Jonathan
Chief Research & Development Officer
Sale2/16/202210,912$10.95$119.5K-71.40%
Thomsen Jillian B
Chief Accounting Officer & Senior Vice President
Sale11/16/20216,741$13.16$88.7K-75.92%
Wilson Mark A /nextkar/
General Counsel & Senior Vice President
Sale11/16/20216,564$13.16$86.4K-75.92%
Page of 6